Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly

Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly

Novo Nordisk is planning to slash the price of several insulin drugs by up to 75% in the U.S., following a similar move by Eli Lilly.

13,371
Like
Save

Comments

Comments are disabled for this post.

Forex SearchClose
Copyright © RichFXM.com. Back to Forex Search